Anvisa records nine deaths due to use of “Covid kit”

The use of the “Covid kit” has caused at least nine deaths from the use of drugs that have not been proven effective against the new coronavirus. The information is from the Pharmacovigilance Notification Panel maintained by the National Health Surveillance Agency (Anvisa) and was released by O Globo.

According to the panel, notifications for adverse effects of chloroquine increased 558%, from 139 in 2019 to 916 in 2020, much higher than the use of other drugs. The majority of reported cases (96%) are from Amazonas. The main reported effects are disorders of the nervous, gastrointestinal, psychiatric and cardiac systems.

The sale of hydroxychloroquine, another drug in the “Covid kit”, which had no notification in 2019, registered 168 notifications for adverse effects, the most common of which were tachycardia, nausea and dizziness. São Paulo was the state with the most records (44%).

Anvisa said that the notifications are only “suspicious” and that they may be associated with the use of other substances.

In a note, the Ministry of Health told O Globo that it is following “all updates and publications regarding the treatment of Covid-19 around the world” and that it will create an advisory board with representatives of medical associations to assist in combating the pandemic.

See too

+ Discovery in the Kalahari desert leads to a review of human origin

+ Contran extends deadline for renewal of CNH

+ Video: step by step how to make Easter egg
+ Platinum Mamba, the knife that is more expensive than a Porsche
+ 5 benefits of intermittent fasting in addition to losing weight
+ Cinema, sex and the city
+ Trick to squeeze lemons becomes a craze on social media
+ Study reveals the healthiest method for cooking rice
+ Shark is captured in MA with remains of young people missing in the stomach
+ Giant anacondas are caught on expeditions of photographers in MS

Source

Get the latest news delivered to your inbox

Follow us on social media networks

PREV BH vaccines elderly 66-year-olds against COVID-19 from this Tuesday (6/4) – General
NEXT Covid-19. APECATE complains of discrimination against touristic animation in the deflation – Observer